Both in Pharmaceuticals
Kardigan vs Syndax Pharmaceuticals
Over the past year KARD returned −27.3% and SNDX returned −23.4%; their daily moves had a correlation of 0.54.
KARD −27.3% SNDX −23.4%Growth of $1, one year, split-adjusted
| Metric | KARD | SNDX |
|---|---|---|
| Price | $13.47 | $13.93 |
| Market cap | $1.26B | $1.24B |
| Today | −0.96% | +1.75% |
| 1 month | −8.1% | −23.6% |
| 6 months | — | −32.5% |
| Year to date | — | −33.7% |
| 1 year | — | +6.3% |
| Revenue growth (YoY) | — | +91.8% |
| Gross margin | — | 95.6% |
| Net margin | — | −67.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 4.9× |
| Net cash | $597.6M | -$41.0M |
| Dividend yield | — | — |
| Volatility (60d) | — | 52.7% |
| Short % of float | 13.8% | 21.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).